GP9 and type 2 diabetes mellitus: In the European population, genetically determined decreased GP9 was associated with T2D, suggesting that decreased galactosylation may increase the risk of T2D, which is consistent with previous studies (Nikolac Perkovic et al. 2014; Liu et al. 2018b).